health clinics in Melbourne (n = 83), their carers (n = 60) and their clinicians (n = 66) completed a questionnaire on the effectiveness, acceptability and side-effects of current, previous and early antipsychotic medicine. Medicine use was determined from clinical records. Results: Patients were predominantly single middleaged women. A signifi cant shift over time toward atypical medicine use had occurred: 66% were currently taking atypicals; compared with early medicines, current medicines were three times more likely to be atypical (odds ratio: 2.95, 95% confi dence interval: 1.48-5.88). Major discrepancies were noted in reports of medicines used between patients, carers, clinicians and clinical notes. Doctors made 61% of all recommendations for changes in previous medicines. There were few signifi cant differences in perceived effectiveness, satisfaction and side-effects when comparing types of medicine. Health-related quality of life was associated with reported side-effects, but not with current medicine type. Conclusions: There is a mutual lack of information and understanding about antipsychotic medicines between patients, their carers and clinicians. Greater reinforcement of provisions and incentives for collaborative treatment planning may be benefi cial. Further studies of the uptake of atypical antipsychotics and their benefi ts should be conducted in real-world settings. Background: Differences in implementation of assertive community treatment (ACT) could explain variability in reported effectiveness.
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A comparison of the implementation of assertive community treatment in Melbourne and London

Methods:
The Pan London Assertive Outreach (PLAO) studies examined ACT implementation and effectiveness amongst 24 London teams (Wright et al. 2003; Billings et al. 2003; Priebe et al. 2003) . The current study gathered data on team organization, staff and client characteristics from four Melbourne ACT teams using identical participant sampling and data collection methods to the PLAO studies (except client characteristics were collected from Melbourne team staff rather than case notes).
Results: Melbourne teams were signifi cantly different from London cluster C teams so comparisons were with cluster A and B teams only. All Melbourne teams worked extended hours; they took greater responsibility for dealing with crises than the London teams. Three of the four Melbourne teams achieved a majority (>70%) of client contacts in vivo compared with only one third of the London teams. There were no signifi cant differences between Melbourne and London teams regarding staff satisfaction and burnout. Client sociodemographic characteristics were very similar. Three quarters of all clients in both countries were admitted in the preceding 2 years but half the bed days were used in Melbourne.
Conclusions: An important difference in the implementation of ACT between Melbourne and London could be home visiting, a postulated 'active component' of models of home-based treatment. Melbourne teams may be more proactive in admitting patients at an earlier stage of relapse.
The impact of the introduction of an acute sedation practice guideline 
